Serine/threonine Phosphatases in Osteoclastogenesis and Bone Resorption

Overview

Journal Gene

Specialty Molecular Biology

Date 2020 Dec 18

PMID 33338510

Citations 9

Authors

Ismael Y Karkache

Jeyaram R Damodaran

David H H Molstad

Elizabeth W Bradley

Affiliations

Soon will be listed here.

Abstract

Maintenance of optimal bone mass is controlled through the concerted functions of several cell types, including bone resorbing osteoclasts. Osteoclasts function to remove calcified tissue during developmental bone modeling, and degrade bone at sites of damage during bone remodeling. Changes to bone homeostasis can arise with alterations in osteoclastogenesis and/or catabolic activity that are not offset by anabolic activity; thus, factors that regulate osteoclastogenesis and bone resorption are of interest to further our understanding of basic bone biology, and as potential targets for therapeutic intervention. Several key cytokines, including RANKL and M-CSF, as well as co-stimulatory factors elicit kinase signaling cascades that promote osteoclastogenesis. These kinase cascades are offset by the action of protein phosphatases, including members of the serine/threonine phosphatase family. Here we review the functions of serine/threonine phosphatases and their control of osteoclast differentiation and function, while highlighting deficiencies in our understanding of this understudied class of proteins within the field.

Citing Articles

Ethanol exposure during differentiation of human induced pluripotent stem cells reduces cardiomyocyte generation and alters metabolism.

Man K, Fu L, Lane A, Harris F, Reid O, Armand L Life Sci. 2025; 364:123434.

PMID: 39892862 PMC: 11834986. DOI: 10.1016/j.lfs.2025.123434.

Regulation of bone homeostasis: signaling pathways and therapeutic targets.

Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M MedComm (2020). 2024; 5(8):e657.

PMID: 39049966 PMC: 11266958. DOI: 10.1002/mco2.657.

Phlpp1 Expression in Osteoblasts Plays a Modest Role in Bone Homeostasis.

Karkache I, Molstad D, Vu E, Jensen E, Bradley E JBMR Plus. 2023; 7(12):e10806.

PMID: 38130760 PMC: 10731110. DOI: 10.1002/jbm4.10806.

Genetic markers associated with bone composition in Rhode Island Red laying hens.

Sallam M, Wilson P, Andersson B, Schmutz M, Benavides C, Dominguez-Gasca N Genet Sel Evol. 2023; 55(1):44.

PMID: 37386416 PMC: 10311847. DOI: 10.1186/s12711-023-00818-x.

Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism.

Wang W, Jiang S, Xu C, Tang L, Liang Y, Zhao Y Front Aging Neurosci. 2022; 14:976316.

PMID: 36408101 PMC: 9667037. DOI: 10.3389/fnagi.2022.976316.

References

Takayanagi H . Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5(12):667-76. DOI: 10.1038/nrrheum.2009.217. View

Rusnak F, Mertz P . Calcineurin: form and function. Physiol Rev. 2000; 80(4):1483-521. DOI: 10.1152/physrev.2000.80.4.1483. View

Salas A, Ponnusamy S, Senkal C, Meyers-Needham M, Selvam S, Saddoughi S . Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood. 2011; 117(22):5941-52. PMC: 3112039. DOI: 10.1182/blood-2010-08-300772. View

Janssens V, Goris J, Van Hoof C . PP2A: the expected tumor suppressor. Curr Opin Genet Dev. 2005; 15(1):34-41. DOI: 10.1016/j.gde.2004.12.004. View

Griffith J, Kim J, Kim E, Sintchak M, Thomson J, Fitzgibbon M . X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 1995; 82(3):507-22. DOI: 10.1016/0092-8674(95)90439-5. View

Ory S, Zhou M, Conrads T, Veenstra T, Morrison D . Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol. 2003; 13(16):1356-64. DOI: 10.1016/s0960-9822(03)00535-9. View

Hirotani H, Tuohy N, Woo J, Stern P, Clipstone N . The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem. 2004; 279(14):13984-92. DOI: 10.1074/jbc.M213067200. View

Ghosh A, Shuman S, Lima C . The structure of Fcp1, an essential RNA polymerase II CTD phosphatase. Mol Cell. 2008; 32(4):478-90. PMC: 2645342. DOI: 10.1016/j.molcel.2008.09.021. View

Huang B, Gudi R, Wu P, Harris R, Hamilton J, Popov K . Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression, and regulation. J Biol Chem. 1998; 273(28):17680-8. DOI: 10.1074/jbc.273.28.17680. View

10.

Izawa T, Zou W, Chappel J, Ashley J, Feng X, Teitelbaum S . c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol. 2012; 32(14):2943-53. PMC: 3416198. DOI: 10.1128/MCB.00077-12. View

11.

Crane J, Xian L, Cao X . Role of TGF-β Signaling in Coupling Bone Remodeling. Methods Mol Biol. 2015; 1344:287-300. DOI: 10.1007/978-1-4939-2966-5_18. View

12.

Shioda N, Fukunaga K . Physiological and Pathological Roles of CaMKII-PP1 Signaling in the Brain. Int J Mol Sci. 2017; 19(1). PMC: 5795971. DOI: 10.3390/ijms19010020. View

13.

Farrell A, Allen-Petersen B, Daniel C, Wang X, Wang Z, Rodriguez S . Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. Mol Cancer Res. 2014; 12(6):924-39. PMC: 4116560. DOI: 10.1158/1541-7786.MCR-13-0542. View

14.

Cohen P . Protein phosphatase 1--targeted in many directions. J Cell Sci. 2002; 115(Pt 2):241-56. DOI: 10.1242/jcs.115.2.241. View

15.

Weber A, Wasiliew P, Kracht M . Interleukin-1 (IL-1) pathway. Sci Signal. 2010; 3(105):cm1. DOI: 10.1126/scisignal.3105cm1. View

16.

Bradley E, Ruan M, Oursler M . PAK1 is a novel MEK-independent raf target controlling expression of the IAP survivin in M-CSF-mediated osteoclast survival. J Cell Physiol. 2008; 217(3):752-8. PMC: 3530845. DOI: 10.1002/jcp.21550. View

17.

Fric J, Lim C, Mertes A, Lee B, Vigano E, Chen J . Calcium and calcineurin-NFAT signaling regulate granulocyte-monocyte progenitor cell cycle via Flt3-L. Stem Cells. 2014; 32(12):3232-44. PMC: 4282522. DOI: 10.1002/stem.1813. View

18.

Varon R, Gooding R, Steglich C, Marns L, Tang H, Angelicheva D . Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome. Nat Genet. 2003; 35(2):185-9. DOI: 10.1038/ng1243. View

19.

Ragolia L, Begum N . Protein phosphatase-1 and insulin action. Mol Cell Biochem. 1998; 182(1-2):49-58. View

20.

Helming L, Tomasello E, Kyriakides T, Martinez F, Takai T, Gordon S . Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal. 2008; 1(43):ra11. PMC: 2673960. DOI: 10.1126/scisignal.1159665. View